Literature DB >> 12058091

Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.

A T Du1, N Schuff, M P Laakso, X P Zhu, W J Jagust, K Yaffe, J H Kramer, B L Miller, B R Reed, D Norman, H C Chui, M W Weiner.   

Abstract

OBJECTIVE: To determine the effects of subcortical ischemic vascular dementia (SIVD) and AD on entorhinal cortex (ERC) and hippocampus.
METHODS: Thirty-eight cognitively normal subjects, 18 patients with SIVD, and 22 patients with AD were included. Volumes of ERC and hippocampus were manually measured based on MRI. Global cerebral changes of cortical gray matter, subcortical gray matter, white matter, sulcal CSF, ventricular CSF (vCSF), and white matter signal hyperintensities (WMSH) were assessed.
RESULTS: Patients with SIVD had 21.7% (p < 0.01) smaller ERC and 18.2% (p < 0.01) smaller hippocampi than cognitively normal subjects and 24.4% (p < 0.01) larger ERC and 11.1% (p < 0.05) larger hippocampi than patients with AD. In addition, patients with SIVD had less cortical gray matter and white matter and more vCSF and WMSH (all p < 0.01) than cognitively normal subjects and more vCSF and WMSH (p < 0.01) than patients with AD. The volumes of ERC and hippocampus were positively correlated to similar extents (p < 0.01) in SIVD and AD. Cortical gray matter loss was positively correlated (p < 0.01) with hippocampal atrophy, but not with ERC atrophy, in SIVD and AD. Hippocampal volume alone could classify 82% of patients with SIVD from cognitively normal subjects and 63% of patients with SIVD from subjects with AD. Adding global cerebral changes to hippocampus substantially improved the classification to 96% between patients with SIVD and cognitively normal subjects and 83% between subjects with SIVD and those with AD, whereas adding ERC change to hippocampus did not significantly improve the discrimination.
CONCLUSIONS: The entorhinal cortex and hippocampus are less affected by subcortical ischemic vascular dementia than by AD.

Entities:  

Mesh:

Year:  2002        PMID: 12058091      PMCID: PMC1820858          DOI: 10.1212/wnl.58.11.1635

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

2.  The clinical diagnosis of Alzheimer's disease.

Authors:  J P Wade; T R Mirsen; V C Hachinski; M Fisman; C Lau; H Merskey
Journal:  Arch Neurol       Date:  1987-01

3.  Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia.

Authors:  M C Tierney; S E Black; J P Szalai; W G Snow; R H Fisher; G Nadon; H C Chui
Journal:  Arch Neurol       Date:  2001-10

4.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.

Authors:  A T Du; N Schuff; D Amend; M P Laakso; Y Y Hsu; W J Jagust; K Yaffe; J H Kramer; B Reed; D Norman; H C Chui; M W Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

5.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.

Authors:  G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Clinicopathological analysis of dementia disorders in the elderly.

Authors:  K Jellinger; W Danielczyk; P Fischer; E Gabriel
Journal:  J Neurol Sci       Date:  1990-03       Impact factor: 3.181

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease.

Authors:  J P Kesslak; O Nalcioglu; C W Cotman
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

9.  MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

Authors:  C R Jack; R C Petersen; P C O'Brien; E G Tangalos
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease.

Authors:  J P Seab; W J Jagust; S T Wong; M S Roos; B R Reed; T F Budinger
Journal:  Magn Reson Med       Date:  1988-10       Impact factor: 4.668

View more
  37 in total

Review 1.  N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.

Authors:  Norbert Schuff; Dieter J Meyerhoff; Susanne Mueller; Linda Chao; Diana Truran Sacrey; Kenneth Laxer; Michael W Weiner
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

2.  The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.

Authors:  Akihiko Shiino; Toshiyuki Watanabe; Yoshitomo Shirakashi; Emi Kotani; Masahiro Yoshimura; Shigehiro Morikawa; Toshiro Inubushi; Ichiro Akiguchi
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

3.  Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.

Authors:  Y Zhang; N Schuff; G-H Jahng; W Bayne; S Mori; L Schad; S Mueller; A-T Du; J H Kramer; K Yaffe; H Chui; W J Jagust; B L Miller; M W Weiner
Journal:  Neurology       Date:  2007-01-02       Impact factor: 9.910

4.  Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis.

Authors:  Hee Jin Kim; Jeonghun Kim; Hanna Cho; Byoung Seok Ye; Cindy W Yoon; Young Noh; Geon Ha Kim; Jae Hong Lee; Jae Seung Kim; Yearn Seong Choe; Kyung-Han Lee; Chang-Hun Kim; Sang Won Seo; Michael W Weiner; Duk L Na; Joon-Kyung Seong
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

5.  Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.

Authors:  Mark W Logue; Holly Posner; Richard C Green; Margaret Moline; L Adrienne Cupples; Katherine L Lunetta; Heng Zou; Stephen W Hurt; Lindsay A Farrer; Charles Decarli
Journal:  Alzheimers Dement       Date:  2011-07-01       Impact factor: 21.566

6.  Morphometry demonstrates loss of cortical thickness in cerebral microangiopathy.

Authors:  Christoph Preul; Gabriele Lohmann; Margret Hund-Georgiadis; Thomas Guthke; D Yves von Cramon
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

7.  Age effects on hippocampal structural changes in old men: the HAAS.

Authors:  Yuan Xu; Daniel J Valentino; Ann I Scher; Ivo Dinov; Lon R White; Paul M Thompson; Lenore J Launer; Arthur W Toga
Journal:  Neuroimage       Date:  2007-12-27       Impact factor: 6.556

8.  Small vessel versus large vessel vascular dementia: risk factors and MRI findings.

Authors:  S S Staekenborg; E C W van Straaten; W M van der Flier; R Lane; F Barkhof; P Scheltens
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

9.  Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.

Authors:  N Schuff; A A Capizzano; A T Du; D L Amend; J O'Neill; D Norman; W J Jagust; H C Chui; J H Kramer; B R Reed; B L Miller; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

Review 10.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.